Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX

NCT01396707 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Metastatic or Recurrent Gastric Adenocarcinoma
Her-2 Positive Gastric Cancer

Interventions

DRUG: Herceptin+XELOX

Sponsor

Asan Medical Center

Collaborators

[object Object]